Table 2 Characteristics of recruited patients with ovarian endometriomas, deep endometriosis and without (controls). Kruskal–Wallis test was used for age while for other data Fisher exact test was used
From: Activation of α7 nicotinic acetylcholine receptor retards the development of endometriosis
Variable | Control (n = 18) | Ovarian Endometriomas (n = 17) | Deep Endometriosis (n = 14) | P-value |
|---|---|---|---|---|
Age (in years) | ||||
Mean ± S.D | 36.3 ± 7.0 | 35.6 ± 7.4 | 38.3 ± 5.4 | 0.53 |
Median (Range) | 36(26–48) | 35(25–48) | 38(27–47 | |
Menstrual phase | ||||
Proliferative Secretory | 12 (66.7%) 6 (33.3%) | 6 (35.3%) 11 (64.7%) | 5 (35.7%) 9 (64.3%) | 0.11 |
Parity | ||||
0 | 4 (22.2%) | 6 (35.3%) | 4 (28.6%) | |
1 | 13 (72.2%) | 8 (47.1%) | 10 (71.4%) | 0.39 |
≥ 2 | 1 (5.6%) | 3 (17.6%) | 0 (0.0%) | |
rASRM score | ||||
Mean ± S.D | NA | 41.6 ± 21.7 | 74.1 ± 22.2 | NA |
Median (Range) | 40 (20–112) | 75 (46–114) | ||
rASRM stage | ||||
I | 0 (0.0%) | 0 (0.0%) | ||
II | NA | 0 (0.0%) | 0 (0.0%) | NA |
III | 7 (41.2%) | 0 (0.0%) | ||
IV | 10 (58.8%) | 14 (100%) | ||
Severity of dysmenorrhea | ||||
None | 18 (100%) | 10 (58.8%) | 0 (0.0%) | |
Mild | 0 (0.0%) | 6 (35.3%) | 4 (28.6%) | 8.3 × 10–11 |
Moderate Severe | 0 (0.0%) 0 (0.0%) | 1 (5.9%) 0(0.0%) | 1 (7.1%) 9 (64.3%) | |
Co-occurrence with uterinefibroids | ||||
No Yes | 18 (100%) 0 (0.0%) | 13 (76.5%) 4 (23.5%) | 8 (57.1%) 6 (42.9%) | 0.006 |
Co-occurrence with adenomyosis | ||||
No Yes | 18 (100%) 0 (0.0%) | 16 (94.1%) 1 (5.9%) | 11 (78.6%) 3 (21.4%) | 0.06 |